Evaluación del efecto del tratamiento combinado de mangiferina con cisplatino y 5-fluorouracilo en células CT26. WT y CHO-K1

Rodríguez González, Julio César; Rodeiro Guerra, Idania; Hernández Balmaceda, Ivones; Delgado Hernández, René.
Rev. cuba. farm ; 48(4): 658-671, oct.-dic. 2014. ilus
Artigo Espanhol | CUMED | ID: cum-61934

Documentos relacionados

  1. Empleo del ultrasonido para la extracción de fracción apolar en hojas de Mangifera indica L. (árbol del mango)
  2. Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study.
  3. AGAPP: efficacy of first-line cisplatin, 5-fluorouracil with afatinib in inoperable gastric and gastroesophageal junction carcinomas. A Hellenic Cooperative Oncology Group study.
  4. Increased HRD score in cisplatin resistant penile cancer cells.
  5. Updates of perioperative multidisciplinary treatment for surgically resectable esophageal cancer.
  6. Efficacy of thoracotomy and thoracoscopic-assisted esophageal surgery in conversion and salvage surgeries: a retrospective study.
  7. Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) as a Neoadjuvant Chemotherapy for Non-metastatic Esophageal Cancer (nMEC).
  8. Prognostic and Predictive Value of Microsatellite Instability, Inflammatory Reaction and PD-L1 in Gastric Cancer Patients Treated with Either Adjuvant 5-FU/LV or Sequential FOLFIRI Followed by Cisplatin and Docetaxel: A Translational Analysis from the ITACA-S Trial.
  9. Value of two-cycle docetaxel, cisplatin, and 5-fluorouracil induction chemotherapy in hypopharyngeal carcinoma.
  10. Predictive factors of toxicity of TPF induction chemotherapy for locally advanced head and neck cancers.